Northwestern Mutual Wealth Management
AVDL

Northwestern Mutual Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$282K – 3574
2023
Q4 		$282K Buy
+20,000
New +$235K ﹤0.01% 1393
2019
Q4 		– Sell
-10,000
Closed -$42K – 2382
2019
Q3 		$42K Hold
10,000
– – ﹤0.01% 1476
2019
Q2 		$29K Hold
10,000
– – ﹤0.01% 1583
2019
Q1 		$14K Hold
10,000
– – ﹤0.01% 1835
2018
Q4 		$26K Buy
+10,000
New +$34K ﹤0.01% 1500

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northwestern Mutual Wealth Management's AVDL Position: Q1 2024 in Review

Northwestern Mutual Wealth Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2024, closing a stake of 20,000 shares — an estimated $282K sold.

Northwestern Mutual Wealth Management first reported a position in AVDL in Q4 2018 and held it in 5 quarters. The position peaked at $282K in Q4 2023. 127 funds tracked by Wall St. Rank hold AVDL as of Q1 2024.

  • Northwestern Mutual Wealth Management reported no remaining Avadel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 20,000 Avadel Pharmaceuticals shares in Q1 2024, an estimated $282K.
  • Northwestern Mutual Wealth Management first reported a position in Avadel Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Avadel Pharmaceuticals position peaked at $282K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.